Malignant tumor
Conditions
Interventions
A group(Drug Treatment):None
B group(Control Solvent):None
Sponsors
Hainan Medical College First Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age: 18 - 80 years old, male or female; 2.Confirmed malignant tumor through histological or cytological diagnosis (including but not limited to colorectal cancer tissue samples and its adjacent tissues, bladder cancer tissue samples and its adjacent tissues, kidney cancer tissue samples and its adjacent tissues, prostate cancer tissue samples and its adjacent tissues); 3.Patients and their families can understand and are willing to participate in this clinical study and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Preoperative neoadjuvant; 2.ASA classification >= IV and/or ECOG performance status score> 2; 3.Persons with severe liver and renal function, cardiopulmonary function, coagulation dysfunction or severe underlying diseases that cannot tolerate surgery; 4.History of severe mental illness; 5.pregnant or lactating women; 6.Persons with a history of taking hormone drugs; 7.Patients with other clinical and laboratory conditions that the investigator believes are inappropriate to participate in this trial;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant differences in efficacy in mice; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient survival and efficacy evaluation; | — |
Countries
China
Contacts
Public ContactJinsheng Wu
Hainan Medical College First Affiliated Hospital
Outcome results
None listed